SOUTH BEND, Ind.-- The Final Beam was set at the Raclin Murphy Encore Center today. This final beam is another step forward at the Morris Performing Arts Center in downtown South Bend.

Guggenheim restated a “buy” rating and set a $78.00 price target on shares of Beam Therapeutics in a research report on Thursday, February 27th. Cantor Fitzgerald upgraded Beam Therapeutics ...